Announced
Completed
Financials
Tags
Biotechnology
biotechnology company
United States
Acquisition
Domestic
Public
Tender Offer
Majority
Friendly
Single Bidder
Completed
Synopsis
MediPacific completed the acquisition of Pardes Biosciences, a company that has focused on discovering, developing and commercializing novel oral antiviral therapeutics to improve the lives of patients suffering from life-threatening disease, for $125m.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.